Related Experiment Video
Updated: May 10, 2025

08:00
Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
10.6K
More of the same? Israel's expanded carrier screening for cystic fibrosis
Tamar Nov-Klaiman1, Ruth Horn2, Aviad Raz3
1Institute for Ethics and History of Health in Society (IEHHS), Faculty of Medicine, University of Augsburg, Augsburg, Germany. tamar.nov.klaiman@med.uni-augsburg.de.
European Journal of Human Genetics : EJHG
|April 25, 2025
Abstract
No abstract available in PubMed .
Related Concept Videos
Cystic Fibrosis: Management
95
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
95
Cystic Fibrosis: Pathogenesis
136
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
136

